Clinical trials for the expansion of indications of endoscopic ultrasound-guided radiofrequency ablation in patients with pancreatic tumors
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0005590
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 38
1. Persons who are able to understand clinical trials of Adults under the age of 20 and under 80 years old who are voluntarily agreed to participate in this clinical trial, voluntarily agreeing to sign consent for this clinical trial.
2. Patients who have been diagnosed with tumors of pancreas and pancreatic tumors using biopsy.
3. Patients who are inoperable or can be operated but not wanted
4. Estimated expectation period of 6 months or more.
5. tumor is identified by CT, MRI or EUS
6. Patients with = 50 % of Karnofsky performance status
7. Patient whose results are normal in the blood coagulation test
8. Patients who follow the clinical trial procedure and comply with the visit schedule.
1. Patient who can not see images of endoscopic ultrasonography.
2. Patients who are taking drugs that can cause bleeding, such as aspirin.
3. Chronic obstructive or restrictive chronic lung disease, including breathing difficulty during recess
4. Other serious diseases or medical conditions.
5. Other medical condition that may impair the ability of patients to participate in clinical trials.
6. Patients with significant neurologic or psychiatric disorder, such as dementia or strokes.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of changes in the size of pancreatic tumours in CT or MRI
- Secondary Outcome Measures
Name Time Method Evaluation of pain level by treatment using pain assessment tool;Assessment of complications based on treatment via CT/MRI, blood tests and abnormal reactions.